Abstract |
We report about 50 patients with inoperable bronchus tumors treated since March 1986 in a prospective non randomized study with high dose rate iridium-192 afterloading (AL) irradiation in 140 applications. 26 patients were treated combined with external irradiation. 32 were treated before with laser therapy, one with chemotherapy ( small cell carcinoma). The actuarial survival rate (Kaplan-Meier) was 26% after 36 weeks for all patients; 38% for combined endoluminal and external irradiation and 9% for patients treated with AL alone. Death was caused by the local tumor in 85%. In 41% lethal bleeding was seen.
|
Authors | H Schedel, R Rohloff, R M Huber, S Duft, R Kantlehner |
Journal | Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
(Strahlenther Onkol)
Vol. 164
Issue 4
Pg. 202-7
(Apr 1988)
ISSN: 0179-7158 [Print] Germany |
Vernacular Title | Endoluminale Bestrahlung mit dem HDR-Iridium-192-Afterloadingverfahren bei tracheobronchialen Tumoren. |
PMID | 2834832
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adenocarcinoma, Bronchiolo-Alveolar
(radiotherapy)
- Brachytherapy
(instrumentation, methods)
- Carcinoma, Bronchogenic
(radiotherapy)
- Carcinoma, Small Cell
(radiotherapy)
- Carcinoma, Squamous Cell
(radiotherapy)
- Humans
- Iridium Radioisotopes
(therapeutic use)
- Lung Neoplasms
(radiotherapy)
- Prospective Studies
- Radiotherapy Dosage
- Tracheal Neoplasms
(radiotherapy)
|